Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
Q3 Revenue up 20% Year-Over-Year to $162.5 Million Q3 Net Income up 139% Year-Over-Year to $5.5 Million Q3 Gross Profit up 40% Year-Over-Year to ...
Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...
New data from Fig highlights how debt and financial stress are deeply tied to emotion, shame and the need for open ...
Bitcoin ETFs have pulled in $247 million in inflows so far this week. Analysts say there are signs of rebound. Others call ...
Donation after circulatory death (DCD) procurements provide an opportunity to alleviate the limited organ supply for solid ...
Revenue up 11% to $254M, driven by strength in physical media and collectibles Adjusted EBITDA up 259% to $12.2M; Gross Margin expands 340 basis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback